BMJ  2006;332:890-894 (15 April), doi:10.1136/bmj.332.7546.890

Clinical review

Systemic lupus erythematosus

¹ Louise Coote Lupus Unit, St Thomas' Hospital, London SE1 7EH david.d'cruz@kcl.ac.uk

The first 150 words of the full text of this article appear below.

Introduction

Systemic lupus erythematosus (SLE) is a multisystem autoimmune connective tissue disorder with various clinical presentations. It is prevalent among young women with a peak age of onset between the late teens and early 40s and a female to male ratio of 9:1. It is more common in certain ethnic groups, such as people with African or Asian ancestry. One study estimated the prevalence of lupus as 27.7/100 000 and as high as 206/100 000 in Afro-Caribbean women.¹ SLE is a chronic illness that may be life threatening when major organs are affected but more commonly results in chronic debilitating ill health. No single cause for SLE has been identified, though factors such as sunlight and drugs may precipitate the condition, and there is a complex genetic basis. Autoantibodies may be present for many years before the clinical onset of the disease, and there may be increasing numbers of antibodies just . . . [Full text of this article]

Sources and selection criteria

Clinical presentation

Management of SLE

Fatigue

Arthralgia and skin rashes

Lupus nephritis

Central nervous system disease

Antiphospholipid (Hughes) syndrome

Cardiovascular risk

Pregnancy, contraceptive pills, and hormone replacement therapy

Novel treatments

Conclusion

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Article

Systemic lupus erythematosus

Lucy H Mackillop, Sarah J Germain, and Catherine Nelson-Piercy
BMJ 2007 335: 933-936. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Garzoni, L., Vanoni, F., Rizzi, M., Simonetti, G. D., Simonetti, B. G., Ramelli, G. P., Bianchetti, M. G. (2009). Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Rheumatology (Oxford) 48: 1524-1529 [Abstract] [Full text]  
• ULFF-MOLLER, C. J., JORGENSEN, K. T., PEDERSEN, B. V., NIELSEN, N. M., FRISCH, M. (2009). Reproductive Factors and Risk of Systemic Lupus Erythematosus: Nationwide Cohort Study in Denmark. The Journal of Rheumatology 36: 1903-1909 [Abstract] [Full text]  
• Mason, J., Bossingham, D (2009). The clinical characterisation of systemic lupus erythematosus in a Far North Queensland Indigenous kindred. Lupus 18: 144-148 [Abstract]  
• Heyneman, C. A. (2009). Systemic Lupus Erythematosus: A Therapeutic Update. Journal of Pharmacy Practice 22: 29-52 [Abstract]  
• Reynolds, J., Toescu, V, Yee, C., Prabu, A, Situnayake, D, Gordon, C (2009). Effects of rituximab on resistant SLE disease including lung involvement. Lupus 18: 67-73 [Abstract]  
• Mackillop, L. H, Germain, S. J, Nelson-Piercy, C. (2007). Systemic lupus erythematosus. BMJ 335: 933-936 [Full text]  
• Deane, J. A., Bolland, S. (2006). Nucleic Acid-Sensing TLRs as Modifiers of Autoimmunity. J. Immunol. 177: 6573-6578 [Abstract] [Full text]  
• (2006). How good at neurology are you? -- ANSWERS. PN 6: 267-267 [Full text]  

Rapid Responses:

Read all Rapid Responses

Fundoscopy in systemic lupus erythematosus

Roger H Armour
bmj.com, 17 Apr 2006 [Full text]

Systemic lupus erythematosis – an ophthalmologist's viewpoint

Mohammad T Masoud, et al.
bmj.com, 18 Apr 2006 [Full text]

SLE incidence has increased with use of contraceptive and menopausal progesterones and oestrogens

Maurizio Cutolo, et al.
bmj.com, 22 Apr 2006 [Full text]

Treatment of cutaneous lupus erythematosus

Susan J Jessop, et al.
bmj.com, 8 May 2006 [Full text]

Treatment of systemic lupus erythematosus

David A Whitelaw, et al.
bmj.com, 8 May 2006 [Full text]

Systemic lupus erythematosus -an example of unetiological medicine

Nikola Ilankovic
bmj.com, 23 May 2006 [Full text]

Re: Treatment of systemic lupus erythematosus

Ellen C G Grant
bmj.com, 24 May 2006 [Full text]

Online poll

Find out more>>